Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

MYOS RENS Technology Inc.

NASDAQ: MYOSHealthcare / Drugs - Generic / USA
1.43-0.27-15.88%Vol 1 522 4731Y Perf 14.18%
Dec 12th, 2018 16:00
BID1.50 ASK1.53
Open1.64 Previous Close1.70
Pre-Market1.55 After-Trading1.51
 -0.15 -8.82%  0.08 5.59%
Target Price
3.50 
Analyst Rating
— 0.00
Potencial %
144.76 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★+     41.00
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
27.21 
Earnings Date
13th Nov 2018

Today's Price Range

1.411.70

 

52wk Range

1.032.50

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Strong Buy
Performance
1 Month
39.34%
3 Months
31.78%
6 Months
13.33%
1 Year
14.18%
3 Years
-3.95%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
MYOS1.43-0.2700-15.88
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.40
Current Ratio
2.00
Long Term Debt to Total Capital
-
Total Debt to Equity
0.26
Interest Coverage
-1 059.00
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
41.80
EBIT Margin
-1 151.10
EBITDA Margin
-1 062.80
Pre-tax Profit Margin
-1 115.10
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.86
PS Ratios
22.14
Price to Cash Flow
-
Price to Free Cash Flow
-2.60
Cash Flow Per Share
-0.46
Price to Tangible Book
5.74
Book Value per Share
0.38
Enterprise Value (in ths.)
8 439
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-93.80
ROE last 12 Months
-117.94
Return on Assets (5Y Avg)
-100.98
ROA last 12 Months
-96.06
Return on Capital (5Y Avg)
-90.12
ROC last 12 Months
-96.94
Return on invested Capital Q
-22.51
Return on invested Capital Y
-83.78
Assets Turnover
0.10
Receivables Turnover
50.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
368
Revenue per Share
0.05
Revenue Growth 3 Years
39.41
Revenue Growth 5 Years
-36.20
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.14-0.1214.29
Q02 2018-0.08-0.14-75.00
Q01 2018-0.08-0.19-137.50
Q02 2016--0.30-
Q01 2016--0.31-
Q01 2015--0.50-
Q03 2014-0.24-0.73-204.17
Q02 2014-0.20-0.32-60.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.140.00-
12/2018 QR-0.14-100.00Negative
12/2018 FY-0.600.00-
12/2019 FY-0.580.00-
Next Report Date-
Estimated EPS Next Report-0.14
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1 522 473
Shares Outstanding (in ths.)6 660
Trades Count2 483
Dollar Volume1 966 340
Avg. Volume216 285
Avg. Weekly Volume4 979 358
Avg. Monthly Volume1 256 464
Avg. Quarterly Volume430 024

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

58%42%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News